Universal Access and Affordable Medicines
About our work on access to medicines
Publications
BeNeLuxA et al.: the best is yet to come
EPHA Response to public consultation on EMA Regulatory Science to 2025
Getting it right: how to improve the European Commission proposal on HTA
Latest Developments
Against COVID-19, let’s make public investments count for people
61 organisations share theit views on the importance of the role of public support to research and development during the current pandemic.
read moreProtect open access to clinical study reports
EPHA joins calls to protect access to clinical trials data ahead of a forthcoming judgment from the European Court of Justice
read moreProtect the public interest in EU health research
EPHA joins calls for the Commission to protect the public interest in the development of the European Partnership on Innovative Health
read moreAnalysis & Opinion
The Top 4 Issues in Medicines Policy for 2020
A snapshot of the themes and trends which will dominate the EU pharmaceutical policy in 2020.
read moreEU Review of Pharmaceutical Incentives – An Opportunity for Change
Ellen ‘t Hoen of Medicines Law and Policy on why it is time to change the system of pharmaceutical incentives in the EU
read moreMedicines shortages – the new cancer of Europe
Calls are growing for concerted EU action to tackle medicines shortages across Europe.
read moreEvents
Time for a new deal
14 November 20194th EPHA Universal Access and Affordable Medicines Forum. Challenging the status quo on medicines policy.
Past events
Putting health first
3 June 2019Trailblazers, routes to better and affordable medicines by 2025
20 November 2018How good are our medicines?
3 October 2018Game changers for better and affordable medicines in Europe
21 November 2017At the European Health Forum Gastein
How good are our medicines? An operational agenda for EU & national policy-makers
Medicines: new games, new rules - Pathways to better and affordable medicines.
“Healthy" innovation: putting patients before profits
Do you have a question?
Meet our Universal Access and Affordable Medicines Policy Lead.
Yannis Natsis
Policy Manager
yannis@epha.org
+32 2 233 3886